420 related articles for article (PubMed ID: 11937125)
1. Effect of clomiphene citrate on follicular and luteal phase luteinizing hormone concentrations in in vitro fertilization cycles stimulated with gonadotropins and gonadotropin-releasing hormone antagonist.
Tavaniotou A; Albano C; Smitz J; Devroey P
Fertil Steril; 2002 Apr; 77(4):733-7. PubMed ID: 11937125
[TBL] [Abstract][Full Text] [Related]
2. Nonsupplemented luteal phase characteristics after the administration of recombinant human chorionic gonadotropin, recombinant luteinizing hormone, or gonadotropin-releasing hormone (GnRH) agonist to induce final oocyte maturation in in vitro fertilization patients after ovarian stimulation with recombinant follicle-stimulating hormone and GnRH antagonist cotreatment.
Beckers NG; Macklon NS; Eijkemans MJ; Ludwig M; Felberbaum RE; Diedrich K; Bustion S; Loumaye E; Fauser BC
J Clin Endocrinol Metab; 2003 Sep; 88(9):4186-92. PubMed ID: 12970285
[TBL] [Abstract][Full Text] [Related]
3. Ovulation triggering in clomiphene citrate-stimulated cycles: human chorionic gonadotropin versus a gonadotropin releasing hormone agonist.
Schmidt-Sarosi C; Kaplan DR; Sarosi P; Essig MN; Licciardi FL; Keltz M; Levitz M
J Assist Reprod Genet; 1995 Mar; 12(3):167-74. PubMed ID: 8520180
[TBL] [Abstract][Full Text] [Related]
4. The impact of LH serum concentration on the clinical outcome of IVF cycles in patients receiving two regimens of clomiphene citrate/gonadotrophin/0.25 mg cetrorelix.
Tavaniotou A; Albano C; Van Steirteghem A; Devroey P
Reprod Biomed Online; 2003 Jun; 6(4):421-6. PubMed ID: 12831586
[TBL] [Abstract][Full Text] [Related]
5. Comparison of luteal phase profile in gonadotrophin stimulated cycles with or without a gonadotrophin-releasing hormone antagonist.
Ragni G; Vegetti W; Baroni E; Colombo M; Arnoldi M; Lombroso G; Crosignani PG
Hum Reprod; 2001 Nov; 16(11):2258-62. PubMed ID: 11679500
[TBL] [Abstract][Full Text] [Related]
6. Impact of clomiphene citrate during ovarian stimulation on the luteal phase after GnRH agonist trigger.
Derksen L; Tournaye H; Stoop D; Van Vaerenbergh I; Bourgain C; Polyzos NP; Haentjens P; Blockeel C
Reprod Biomed Online; 2014 Mar; 28(3):359-68. PubMed ID: 24456700
[TBL] [Abstract][Full Text] [Related]
7. A single injection of a gonadotropin-releasing hormone (GnRH) antagonist (Cetrorelix) postpones the luteinizing hormone (LH) surge: further evidence for the role of GnRH during the LH surge.
Leroy I; d'Acremont M; Brailly-Tabard S; Frydman R; de Mouzon J; Bouchard P
Fertil Steril; 1994 Sep; 62(3):461-7. PubMed ID: 8062939
[TBL] [Abstract][Full Text] [Related]
8. Early luteal phase endocrine profile is affected by the mode of triggering final oocyte maturation and the luteal phase support used in recombinant follicle-stimulating hormone-gonadotropin-releasing hormone antagonist in vitro fertilization cycles.
Fatemi HM; Polyzos NP; van Vaerenbergh I; Bourgain C; Blockeel C; Alsbjerg B; Papanikolaou EG; Humaidan P
Fertil Steril; 2013 Sep; 100(3):742-7. PubMed ID: 23806846
[TBL] [Abstract][Full Text] [Related]
9. Revival of the natural cycles in in-vitro fertilization with the use of a new gonadotrophin-releasing hormone antagonist (Cetrorelix): a pilot study with minimal stimulation.
Rongières-Bertrand C; Olivennes F; Righini C; Fanchin R; Taïeb J; Hamamah S; Bouchard P; Frydman R
Hum Reprod; 1999 Mar; 14(3):683-8. PubMed ID: 10221695
[TBL] [Abstract][Full Text] [Related]
10. Comparison of LH concentrations in the early and mid-luteal phase in IVF cycles after treatment with HMG alone or in association with the GnRH antagonist Cetrorelix.
Tavaniotou A; Albano C; Smitz J; Devroey P
Hum Reprod; 2001 Apr; 16(4):663-7. PubMed ID: 11278214
[TBL] [Abstract][Full Text] [Related]
11. Subtle progesterone rise in the single-dose gonadotropin-releasing hormone antagonist (cetrorelix) stimulation protocol in patients undergoing in vitro fertilization or intracytoplasmic sperm injection cycles.
Seow KM; Lin YH; Huang LW; Hsieh BC; Huang SC; Chen CY; Chen PH; Tzeng CR; Hwang JL
Gynecol Endocrinol; 2007 Jun; 23(6):338-42. PubMed ID: 17616858
[TBL] [Abstract][Full Text] [Related]
12. Pulsatility of serum-luteinizing hormone during hyperstimulation with clomiphene citrate and human menopausal gonadotropin for in vitro fertilization.
Wolfram J; Siegberg R; Apter D; Alfthan H; Stenman UH; Laatikainen T
Fertil Steril; 1989 Nov; 52(5):817-20. PubMed ID: 2509253
[TBL] [Abstract][Full Text] [Related]
13. Differential effects of gonadotrophin-releasing hormone agonists administered as desensitizing or flare protocols on hormonal function in the luteal phase of hyperstimulated cycles.
Norman RJ; Warnes GM; Wang X; Kirby CA; Matthews CD
Hum Reprod; 1991 Feb; 6(2):206-13. PubMed ID: 1905309
[TBL] [Abstract][Full Text] [Related]
14. Altered follicular development in clomiphene citrate versus human menopausal gonadotropin-stimulated cycles for in vitro fertilization.
Dlugi AM; Laufer N; Botero-Ruiz W; DeCherney AH; Polan ML; Haseltine FP; Mezer HC; Behrman HR
Fertil Steril; 1985 Jan; 43(1):40-7. PubMed ID: 3155509
[TBL] [Abstract][Full Text] [Related]
15. The luteal phase of nonsupplemented cycles after ovarian superovulation with human menopausal gonadotropin and the gonadotropin-releasing hormone antagonist Cetrorelix.
Albano C; Grimbizis G; Smitz J; Riethmüller-Winzen H; Reissmann T; Van Steirteghem A; Devroey P
Fertil Steril; 1998 Aug; 70(2):357-9. PubMed ID: 9696235
[TBL] [Abstract][Full Text] [Related]
16. Daily low-dose hCG stimulation during the luteal phase combined with GnRHa triggered IVF cycles without exogenous progesterone: a proof of concept trial.
Andersen CY; Elbaek HO; Alsbjerg B; Laursen RJ; Povlsen BB; Thomsen L; Humaidan P
Hum Reprod; 2015 Oct; 30(10):2387-95. PubMed ID: 26209535
[TBL] [Abstract][Full Text] [Related]
17. The luteal phase of recombinant follicle-stimulating hormone/gonadotropin-releasing hormone antagonist in vitro fertilization cycles during supplementation with progesterone or progesterone and estradiol.
Fatemi HM; Camus M; Kolibianakis EM; Tournaye H; Papanikolaou EG; Donoso P; Devroey P
Fertil Steril; 2007 Mar; 87(3):504-8. PubMed ID: 17140572
[TBL] [Abstract][Full Text] [Related]
18. A randomized controlled study comparing the endocrine effects of pulsatile intravenous gonadotropin-releasing hormone after gonadotropin-releasing hormone agonist pretreatment versus clomiphene citrate in patients with polycystic ovary syndrome.
Timmerman-van Kessel EC; Cikot RJ; Dargel-Donkers EJ; Zwertbroek W; van Dop PA; Schoot DC
Fertil Steril; 2000 Jun; 73(6):1145-8. PubMed ID: 10856472
[TBL] [Abstract][Full Text] [Related]
19. Gonadotropin-releasing hormone antagonist versus agonist administration in women undergoing controlled ovarian hyperstimulation: cycle performance and in vitro steroidogenesis of granulosa-lutein cells.
Minaretzis D; Alper MM; Oskowitz SP; Lobel SM; Mortola JF; Pavlou SN
Am J Obstet Gynecol; 1995 May; 172(5):1518-25. PubMed ID: 7755066
[TBL] [Abstract][Full Text] [Related]
20. [Hormone profile and follicle development in ovarian stimulation treatment for in vitro fertilization. II. Prolactin, estradiol and progesterone profile].
Sudik R; Fliess FR; Kunkel S
Zentralbl Gynakol; 1989; 111(9):567-80. PubMed ID: 2500795
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]